Intravenous Iron Therapy Guidelines for Hemodialysis Patients

Preferred Route of Administration

Initiation and Withholding Thresholds

Loading Phase Dosing

Maintenance Phase Dosing

Monitoring Parameters

Safety and Administration Protocols

Expected Hematologic Response and Reassessment

Pediatric Dosing Adjustments (Iron Dextran)

IV Iron Administration Guidelines

Introduction to IV Iron Therapy

• The National Comprehensive Cancer Network recommends IV iron should be administered according to specific regimens based on the iron preparation used, with test doses required for iron dextran and strongly recommended for other preparations in patients with previous sensitivities 6, 7

Iron Preparation Options

• Three main parenteral iron preparations are used clinically: iron dextran, ferric gluconate, and iron sucrose 6
• If using iron dextran, low-molecular-weight iron dextran (INFed) is recommended over high-molecular-weight iron dextran (Dexferrum) due to fewer adverse events 6
• Patients with active infection should not receive IV iron therapy 6

Administration Protocols by Preparation

Iron Dextran

• Test dose: 25 mg slow IV push and wait 1 hour before giving main dose (required) 6
• Dosage: 100 mg IV over 5 minutes 6
• Regimen options:
• Maximum total dose: 1000 mg 6
• For CKD, home hemodialysis, or PD patients: Can administer single doses of 500-1000 mg diluted in 250 mL normal saline infused over 1 hour 8, 9

Ferric Gluconate (Ferrlecit)

• Test dose: 25 mg slow IV push or infusion (at physician discretion, but strongly recommended for patients with previous sensitivities) 6, 7
• Adult dosage: 125 mg IV over 60 minutes 6, 7
• Repeated dosing given once weekly for 8 doses 6
• Individual doses above 125 mg are not recommended 6
• Maximum total dose: 1000 mg 6

Iron Sucrose

• Test dose: 25 mg slow IV push (at physician discretion, but strongly recommended for patients with previous sensitivities) 6, 7
• Dosage: 200 mg IV over 60 minutes 6
• Repeated dosing given every 2-3 weeks 6
• Individual doses above 300 mg are not recommended 6

Special Populations

Pediatric Dosing

• Iron dextran for pediatric hemodialysis patients (10-dose course):
• Iron dextran for pediatric predialysis and PD patients:

Monitoring and Maintenance

• For hemodialysis patients: Maintenance IV iron can be given thrice weekly, twice weekly, weekly, or every other week, providing 250-1000 mg within 12 weeks 11
• Monitor iron status by measuring transferrin saturation (TSAT) and serum ferritin every 3 months during maintenance phase 11
• Target iron levels: TSAT ≥20% and serum ferritin ≥100 ng/mL 8
• Avoid measuring iron parameters within 7-14 days after IV iron administration for accurate results 11

Safety Considerations

• Common adverse events include hypotension, hypertension, nausea, vomiting, diarrhea, pain, fever, dyspnea, pruritus, headaches, and dizziness 6

Practical Considerations

• IV iron is preferable for hemodialysis patients and may be appropriate for some peritoneal dialysis and CKD patients not on dialysis 10

Timing and Practical Considerations for Intravenous Iron in Hemodialysis Patients

Advantages of Administration During or After Dialysis

• Using the existing vascular access eliminates the need for an additional venipuncture when iron is given during or immediately after the dialysis session – this improves patient convenience and reduces procedural risk in adult hemodialysis patients receiving iron sucrose. 12

Disadvantages of Administration Before Dialysis

• Providing iron before the dialysis session would require patients to arrive significantly earlier, which can lower treatment adherence – in the hemodialysis population, earlier arrival times are associated with reduced compliance with scheduled dialysis. 12

Iron Sucrose Dosing, Monitoring, and Maintenance in Hemodialysis Patients

Iron Parameter Changes After Loading Dose

• In hemodialysis patients receiving a total of 1,000 mg iron sucrose (200 mg weekly × 5), transferrin saturation (TSAT) rises by approximately 8–10 % 13.

Laboratory Monitoring After Loading Dose

• TSAT and serum ferritin should be re‑checked 4–8 weeks after the final 200 mg dose to evaluate true response; testing earlier than 7 days after a dose yields falsely elevated values 13.
• Target iron parameters to support erythropoiesis are TSAT ≥ 20 % and serum ferritin ≥ 100 ng/mL 13.

Transition to Maintenance Therapy

• After completing the 5‑dose loading regimen, patients should move to a maintenance schedule delivering 250–1,000 mg IV iron within each 12‑week period, administered weekly, every other week, or with each dialysis session (thrice weekly) according to individual iron losses [13][14].
• Because chronic blood losses in hemodialysis average 1–3 g of iron per year, most patients require ongoing IV iron; oral iron alone cannot maintain adequate stores 13.
• During the maintenance phase, TSAT and ferritin should be monitored every 3 months to guide further dosing [13][14].

Practical Advantages of the 200 mg Weekly Regimen

• Weekly 200 mg dosing is more convenient than the older 100 mg twice‑weekly schedule, reducing the number of visits from 10 to 5 per loading course [13][15].
• The 200 mg weekly regimen is as effective as iron dextran 100 mg weekly for 10 weeks but avoids the higher anaphylaxis risk associated with dextran formulations [13][14].